Double dose of dolutegravir to treat HIV in children also being treated for tuberculosis
2022
Results from a substudy of the ODYSSEY trial show that children being treated for tuberculosis (TB) and HIV at the same time can safely have the anti-HIV medicine dolutegravir twice a day.